MedTrace Logo

Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCA

NCT02448862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10575

Last updated 2016-05-02

Study results available
· View outcomes & findings →

Summary

In this retrospective study, postoperative pain score, PCA-related complications, the risk factors for requirement of rescue analgesics and antiemetics will be evaluated in young and elderly patients, respectively, using fentanyl-based IV PCA during postoperative 48 hours after various surgeries.

Conditions

  • Pain, Postoperative
  • Postoperative Nausea and Vomiting

Interventions

DEVICE

Fentanyl based IV-PCA

We have used a disposable PCA pump (Ambix Anaplus®; E-Wha Fresenius Kabi, Korea or accufuser plus®; Woo Young Medical, Korea) and fentanyl was diluted in 100 mL with saline for 48 hrs PCA infusion. The pump was set as follows: infusion rate as 2 ml/hr, bolus dose as 0.5 ml or 1 ml, lockout time as 15 min. It was decided at the anesthesiologist's option whether the additional analgesic drug (ketorolac or nefopam) and the antiemetic drug (ondansetron, ramosetron or palonosetron) would be added in PCA or not. The anesthesiologist who performed the anesthesia decided the amount of chosen drugs.

Sponsors & Collaborators

  • Severance Hospital

    lead OTHER

Principal Investigators

  • Jae Chul Koh, MD · Gang Nam Severance Hospitial

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448862 on ClinicalTrials.gov